These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 15577535)

  • 21. Is population-level perversity a likely outcome of mass vaccination against HIV?
    Bogaards JA; van Ballegooijen WM; Jan Weverling G; Boerlijst MC; Goudsmit J
    Lancet Infect Dis; 2005 May; 5(5):254; author reply 255-6. PubMed ID: 15854875
    [No Abstract]   [Full Text] [Related]  

  • 22. AIDS vaccine: efficacy, safety and ethics.
    Veljkovic V; Veljkovic N; Glisic S; Ho MW
    Vaccine; 2008 Jun; 26(24):3072-7. PubMed ID: 18164521
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Patients' high acceptability of a future therapeutic HIV vaccine in France: a French paradox?
    Dimi S; Zucman D; Chassany O; Lalanne C; Prazuck T; Mortier E; Majerholc C; Aubin-Auger I; Verger P; Duracinsky M
    BMC Infect Dis; 2019 May; 19(1):401. PubMed ID: 31072394
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Executive summary and recommendations from WHO/UNAIDS and AAVP consultation on: 'The inclusion of adolescents in HIV vaccine trials', 16-18 March 2006 in Gaborone, Botswana.
    ; Osmanov S
    AIDS; 2007 Sep; 21(14):W1-10. PubMed ID: 17721089
    [TBL] [Abstract][Full Text] [Related]  

  • 25. HIV gp120 vaccine gene therapy (Wyeth-Lederle Vaccines-Malvern).
    Drugs R D; 1999 Jun; 1(6):448. PubMed ID: 10566079
    [No Abstract]   [Full Text] [Related]  

  • 26. HIV gp120 vaccine (Chiron).
    Drugs R D; 1999 Jun; 1(6):445-7. PubMed ID: 10566078
    [No Abstract]   [Full Text] [Related]  

  • 27. A scientific overview of the development of AIDS vaccines.
    Little K; Surjadi M
    J Assoc Nurses AIDS Care; 2000; 11(6):19-28. PubMed ID: 11082799
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Nurses at the forefront of a pandemic: HIV/AIDS nurses.
    Kirton C
    Imprint; 2007; 54(3):54-7, 62. PubMed ID: 17500298
    [No Abstract]   [Full Text] [Related]  

  • 29. First Phase II AIDS vaccine trial begins in South Africa.
    IAVI Rep; 2005; 9(5):19. PubMed ID: 16541503
    [No Abstract]   [Full Text] [Related]  

  • 30. Thorny issues in the ethics of AIDS vaccine trials.
    Berkley S
    Lancet; 2003 Sep; 362(9388):992. PubMed ID: 14513850
    [No Abstract]   [Full Text] [Related]  

  • 31. HIV vaccines: an attainable goal?
    Reynell L; Trkola A
    Swiss Med Wkly; 2012; 142():w13535. PubMed ID: 22389197
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Paralysis in AIDS vaccine development violates ethical principles and human rights.
    Mann JM
    J Int Assoc Physicians AIDS Care; 1998 May; 4(5):42-3. PubMed ID: 11365188
    [TBL] [Abstract][Full Text] [Related]  

  • 33. HIV vaccine trial preparedness among Spanish-speaking Latinos in the US.
    Brooks RA; Newman PA; Duan N; Ortiz DJ
    AIDS Care; 2007 Jan; 19(1):52-8. PubMed ID: 17129857
    [TBL] [Abstract][Full Text] [Related]  

  • 34. First trial of the HIV-1 vaccine in Africa: Ugandan experience.
    Mugerwa RD; Kaleebu P; Mugyenyi P; Katongole-Mbidde E; Hom DL; Byaruhanga R; Salata RA; Ellner JJ;
    BMJ; 2002 Jan; 324(7331):226-9. PubMed ID: 11809648
    [No Abstract]   [Full Text] [Related]  

  • 35. Don't stop me now.
    Nat Immunol; 2008 Aug; 9(8):821. PubMed ID: 18645584
    [No Abstract]   [Full Text] [Related]  

  • 36. [HIV infection--current challenges].
    Salzberger B; Fätkenheuer G; Diehl V
    Internist (Berl); 2003 Jun; 44(6):675-7. PubMed ID: 14567103
    [No Abstract]   [Full Text] [Related]  

  • 37. Vaccine characteristics and acceptability of HIV immunization among adolescents.
    Zimet GD; Blythe MJ; Fortenberry JD
    Int J STD AIDS; 2000 Mar; 11(3):143-9. PubMed ID: 10726935
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A small dose of HIV? HIV vaccine mental models and risk communication.
    Newman PA; Seiden DS; Roberts KJ; Kakinami L; Duan N
    Health Educ Behav; 2009 Apr; 36(2):321-33. PubMed ID: 18032589
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Vaccine trial results generate debate and calls for further research.
    Garmaise D
    Can HIV AIDS Policy Law Rev; 2003 Apr; 8(1):44-5. PubMed ID: 12924310
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Barriers of enrolment in HIV vaccine trials: a review of HIV vaccine preparedness studies.
    Dhalla S; Poole G
    Vaccine; 2011 Aug; 29(35):5850-9. PubMed ID: 21740947
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.